News Releases

Anixa Biosciences Appoints Suyasha Gupta as Senior Director of Clinical Development

October 7, 2024

Anixa Biosciences Announces Submission of Protocol Amendment for CAR-T Trial

September 30, 2024

Anixa Biosciences Unveils Phase 2 Study Plan for Breast Cancer Vaccine

September 24, 2024

Anixa Biosciences Announces Presentation on its Ovarian Cancer CAR-T Therapy at the Ovarian Cancer Research Alliance's International Gynecologic Cancer Conference

September 18, 2024

Anixa Biosciences Announces Presentation on its Ovarian Cancer CAR-T Therapy at the Rivkin Center-AACR 15th Biennial Ovarian Cancer Research Symposium

September 3, 2024

Anixa Biosciences to Present at the H.C. Wainwright 26th Annual Global Investment Conference

August 26, 2024

Anixa Biosciences Announces Presentation on its Ovarian Cancer CAR-T Clinical Trial at the International Gynecologic Cancer Society 2024 Annual Meeting

July 29, 2024

Anixa Biosciences Announces FDA Approval of Individual Patient IND for its Ovarian Cancer CAR-T Therapy

July 23, 2024

Anixa Biosciences Announces Japanese Patent on Breast Cancer Vaccine Technology

July 17, 2024

Anixa Biosciences Announces $5 Million Share Repurchase Program

July 15, 2024

Latest News & Events

Oct 7, 2024

Anixa Biosciences Appoints Suyasha Gupta as Senior Director of Clinical Development

Read More...

Sep 30, 2024

Anixa Biosciences Announces Submission of Protocol Amendment for CAR-T Trial

Read More...

Sep 24, 2024

Anixa Biosciences Unveils Phase 2 Study Plan for Breast Cancer Vaccine

Read More...